1. Home
  2. IDXX vs NTRA Comparison

IDXX vs NTRA Comparison

Compare IDXX & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEXX Laboratories Inc.

IDXX

IDEXX Laboratories Inc.

HOLD

Current Price

$556.20

Market Cap

45.4B

Sector

Health Care

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$258.03

Market Cap

39.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDXX
NTRA
Founded
1983
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.4B
39.1B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
IDXX
NTRA
Price
$556.20
$258.03
Analyst Decision
Buy
Strong Buy
Analyst Count
9
15
Target Price
$721.67
$259.07
AVG Volume (30 Days)
592.1K
1.1M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
22.59
0.65
EPS
3.47
N/A
Revenue
$4,303,702,000.00
$210,939,000.00
Revenue This Year
$10.88
$18.08
Revenue Next Year
$8.59
$19.65
P/E Ratio
$156.86
N/A
Revenue Growth
10.42
N/A
52 Week Low
$518.55
$131.81
52 Week High
$769.98
$288.04

Technical Indicators

Market Signals
Indicator
IDXX
NTRA
Relative Strength Index (RSI) 50.84 50.49
Support Level $549.60 $186.96
Resistance Level $583.93 $288.04
Average True Range (ATR) 16.50 10.42
MACD -1.00 -3.74
Stochastic Oscillator 47.99 15.47

Price Performance

Historical Comparison
IDXX
NTRA

About IDXX IDEXX Laboratories Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: